Invesco Portfolio holdings
Invesco is an investment management company that launched the Invesco QQQ exchange-traded fund in 1999, back when it operated as Amvescap. Invesco QQQ tracks the Nasdaq-100 index of companies listed on Nasdaq. Invesco traces its roots to H. Lotery & Co., a UK advisory firm formed in 1935, and in 1978 Charles Brady and eight partners bought the money management arm of Citizens & Southern National Bank, then called INVESCO. It bought PowerShares Capital Management, sponsor of 36 exchange-traded funds, in 2006, and in 2007 it went back to the Invesco name and moved its legal home to Bermuda. Its 2009 purchase of Morgan Stanley's retail unit brought in Van Kampen Investments, and in 2019 it acquired OppenheimerFunds from Massachusetts Mutual Life Insurance Company. It serves retail and institutional investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sandisk
SNDK
|
+$6.35B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$2.84B |
| 3 |
Arm
ARM
|
+$1.84B |
| 4 |
Lumentum
LITE
|
+$1.78B |
| 5 |
Teradyne
TER
|
+$1.57B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco NASDAQ 100 ETF
QQQM
|
+$2.26B |
| 2 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$2.2B |
| 3 |
Honeywell
HON
|
+$2.2B |
| 4 |
Dell
DELL
|
+$1.69B |
| 5 |
Insmed
INSM
|
+$744M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 44.02% |
| 2 | Consumer Discretionary | 9.38% |
| 3 | Communication Services | 9.23% |
| 4 | Industrials | 8.59% |
| 5 | Healthcare | 7.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3551
First Northern Community Bancorp
FNRN
$279M
| $184K | ﹤0.01% |
+10,234
| New | +$178K |
2026 Q2
0 quarters
|
|
3552
LexinFintech Holdings
LX
$106M
| $183K | ﹤0.01% |
93,118
-12,936
| -12% | -$27.6K |
2018 Q2
32 quarters
|
|
3553
Wealthfront Corp
WLTH
$1.65B
| $183K | ﹤0.01% |
20,452
-758
| -4% | -$7.89K |
2025 Q4
2 quarters
|
|
3554
Standard BioTools
LAB
$245M
| $183K | ﹤0.01% |
221,906
-36,438
| -14% | -$34.4K |
2023 Q4
10 quarters
|
|
3555
TechTarget
TTGT
$255M
| $181K | ﹤0.01% |
50,309
+4,651
| +10% | +$21.3K |
2014 Q2
48 quarters
|
|
3556
Adagene
ADAG
$169M
| $180K | ﹤0.01% |
42,945
-4,179
| -9% | -$15.7K |
2026 Q1
1 quarter
|
|
3557
Perspective Therapeutics
CATX
$131M
| $180K | ﹤0.01% |
52,866
-178,489
| -77% | -$674K |
2024 Q2
8 quarters
|
|
3558
Whitehawk Therapeutics
WHWK
$188M
| $179K | ﹤0.01% |
+39,179
| New | +$163K |
2026 Q2
0 quarters
|
|
3559
Bausch + Lomb
BLCO
$7.15B
| $178K | ﹤0.01% |
10,753
-463
| -4% | -$7.36K |
2025 Q4
2 quarters
|
|
3560
Nexxen International
NEXN
$505M
| $177K | ﹤0.01% |
19,556
-7,831
| -29% | -$61.8K |
2025 Q2
4 quarters
|
|
3561
NexGen Energy
NXE
$5.55B
| $175K | ﹤0.01% |
18,612
-1,165,384
| -98% | -$13.2M |
2021 Q2
20 quarters
|
|
3562
Haleon
HLN
$38.1B
| $175K | ﹤0.01% |
18,708
+825
| +5% | +$7.67K |
2022 Q3
15 quarters
|
|
3563
Goldgroup Mining
GORO
$554M
| $174K | ﹤0.01% |
+34,549
| New | +$189K |
2026 Q2
0 quarters
|
|
3564
Heron Therapeutics
HRTX
$52.7M
| $174K | ﹤0.01% |
406,668
+80,156
| +25% | +$64.3K |
2015 Q2
44 quarters
|
|
3565
Duos Technologies
DUOT
$203M
| $172K | ﹤0.01% |
+14,325
| New | +$144K |
2026 Q2
0 quarters
|
|
3566
Dingdong
DDL
$422M
| $171K | ﹤0.01% |
88,400
-12,268
| -12% | -$30.5K |
2023 Q2
12 quarters
|
|
3567
Algoma Steel
ASTL
$504M
| $170K | ﹤0.01% |
42,054
-17,096
| -29% | -$82.1K |
2022 Q3
15 quarters
|
|
3568
Fennec Pharmaceuticals
FENC
$359M
| $169K | ﹤0.01% |
15,744
+4,067
| +35% | +$33.2K |
2025 Q2
4 quarters
|
|
3569
Forum Markets
FRMM
$45.5M
| $169K | ﹤0.01% |
31,069
-21,728
| -41% | -$95K |
2025 Q4
2 quarters
|
|
3570
Universal Logistics Holdings
ULH
$596M
| $168K | ﹤0.01% |
11,375
-1,905
| -14% | -$34K |
2019 Q1
29 quarters
|
|
3571
Vuzix
VUZI
$179M
| $167K | ﹤0.01% |
57,733
-696
| -1% | -$2.19K |
2024 Q4
6 quarters
|
|
3572
JELD-WEN Holding
JELD
$109M
| $167K | ﹤0.01% |
111,277
-70,515
| -39% | -$109K |
2017 Q4
34 quarters
|
|
3573
TSS Inc
TSSI
$194M
| $166K | ﹤0.01% |
13,532
-1,440
| -10% | -$19.4K |
2025 Q2
4 quarters
|
|
3574
NexPoint Real Estate Finance
NREF
$289M
| $166K | ﹤0.01% |
10,694
-720
| -6% | -$10.7K |
2025 Q4
2 quarters
|
|
3575
Medallion Financial
MFIN
$228M
| $163K | ﹤0.01% |
15,997
-5,276
| -25% | -$49.9K |
2024 Q1
9 quarters
|
|
Similar funds
Invesco's Q2 2026 Portfolio in Review
As of Q2 2026, Invesco held 3,969 positions worth $1.26T, up 23% from $1.02T the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Invesco's Q2 2026 filing shows 214 new, 1,806 increased, 1,705 reduced and 150 closed positions. Its largest new stake was Honeywell Aerospace: 12,884,435 shares worth $2.85B. The largest sale was Invesco NASDAQ 100 ETF, an estimated $2.26B.
By sector, the portfolio is most concentrated in Technology at 44% of assets, up from 35% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Invesco's largest Q2 2026 buy was Honeywell Aerospace: 12,884,435 shares worth $2.85B.
- Invesco added most to Sandisk in Q2 2026, an estimated $6.35B increase.
- Invesco's biggest Q2 2026 reduction was Invesco NASDAQ 100 ETF, cutting an estimated $2.26B.
- Invesco fully exited Coterra Energy in Q2 2026, selling an estimated $394M.
- Invesco's ten largest holdings make up 29% of its $1.26T portfolio in Q2 2026.
- Invesco opened 214 new positions and closed 150 in Q2 2026.
- Invesco's portfolio value rose 23% quarter-over-quarter to $1.26T.
Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.